New Imaging Technologies To Characterize Arrhythmic Substrate by A.D. Russo et al.
www.jafib.com Dec 2014-Jan 2015| Volume 7| Issue 4
New Imaging Technologies To Characterize Arrhythmic Substrate
Antonio Dello Russo, MD, PhD, Sergio Conti, MD, Ghaliah Al-Mohani, MD, Phd, Michela Casella, MD, PhD, 
Francesca Pizzamiglio, MD, Corrado Carbucicchio, MD, Stefania Riva, MD, Gaetano Fassini, MD, Massimo 
Moltrasio, MD, Fabrizio Tundo, MD, PhD, Martina Zucchetti, MD, Benedetta Majocchi, MD, Eleonora Russo, 
MD, Vittoria Marino, MD, Fabrizio Bologna, MD, Luigi Di Biase, MD, PhD,* Andrea Natale, MD,* Claudio Tondo 
, MD, PhD
Cardiac Arrhythmia Research Centre, Centro Cardiologico Monzino IRCCS, Milan, Italy. *St. David’s Medical Center , 
Cardiac Arrhythmia Institute, Austin Texas, USA
Abstract
The cornerstone of the new imaging technologies to treat complex arrhythmias is the electroanatomic (EAM) mapping. It is based on 
tissue characterization and in particular on determination of low potential region and dense scar definition. Recently, the identification of 
fractionated isolated late potentials increased the specificity of the information derived from EAM. In addition, non-invasive tools and their 
integration with EAM, such as cardiac magnetic resonance imaging and computed tomography scanning, have been shown to be helpful to 
characterize the arrhythmic substrate and to guide the mapping and the ablation. Finally, intracardiac echocardiography, known to be useful 
for several practical uses in the setting of electrophysiological procedures, it has been also demonstrated to provide important informations 
about the anatomical substrate and may have potential to identify areas of scarred myocardium.
Introduction
In the last years our understanding of the arrhythmic substrate in 
various cardiomyopathies, resulting in substrate-based approaches 
for targeted complex arrhythmias ablation was improved. Further, 
the growth in better technologies and techniques for complex 
procedures such as atrial fibrillation (AF), left atrial flutter and 
ventricular tachycardia (VT) ablation have overcome the limitations 
and greatly improved the success rates of radiofrequency catheter 
ablation (RFCA). This review summarizes the relationship between 
the arrhythmic substrate feature sand and novel approaches in the 
new technologies for RFCA of complex arrhythmias.
Anatomopathological Features Underlying Arrhythmia 
Induction
VT in the context of ischemic cardiomyopathy are caused by 
reentry involving a ventricular scar. During the infarct healing 
process, necrotic myocardium is replaced with fibrous tissue. Dense 
fibrotic scar creates areas of anatomical conduction block, and fibrosis 
between surviving myocytes decreases cellular coupling and distorts 
the path of propagation causing areas of slow conduction and block, 
which promotes reentry. Endocardial recordings from sites of VT 
origin during sinus rhythm consistently demonstrate low-amplitude, 
prolonged, multicomponent potentials. The duration of the local 
electrogram represents the abnormally slow, fractionated conduction. 
Differently, arrhythmogenic right ventricular cardiomyopathy/
dysplasia (ARVC/D) involves primarily the right ventricle (RV). 
In this condition, portions of the RV are replaced by fibro-fatty 
tissue. Focal inflammation and necrosis can be seen at histologic 
study. The interventricular septum and left ventricle may also show 
involvement. VT are common in ARVC/D because of the extensive 
myocardial fibrosis that provides the substrate for reentry. Also in 
non-ischemic dilated cardiomyopathy the myocardial fibrosis is an 
important factor in the substrate leading to VT. However, in patients 
with non-ischemic cardiomyopathy the cause of fibrosis is not well 
defined. The reentry circuits are typically associated with regions of 
low voltage electrograms, consistent with scar.1,2
Arrhythmogenic Substrate And Scar Identification By 
Electroanatomic Mapping
Electroanatomic mapping (EAM) systems have been introduced 
into clinical electrophysiology in 1997.3-5 Sinus-rhythm EAM 
was found to identify infarct areas in animal models.6,7 In human 
studies, however, high-density EAM scar definition using multiple 
electrogram (EGM) parameters has been matched against a gold-
standard technique based on tissue characterization and validation 
studies have confirmed that low voltage corresponds to the presence 
of scar defined by delayed enhanced MRI (DE-MRI).8 This 
comparison was first evaluated in the study of Codreanu and co-
workers, which confirmed that bipolar EGM characteristics could 
reliably differentiate scar from healthy tissue.9 The most important 
EGM characteristic initially analyzed was bipolar peak-to-peak 
voltage. This was shown to be a powerful discriminant of scarred areas 
from background normal myocardium when, after analysis of post-
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EGM sites and entrainment maneuvers show a mean stimulus-QRS 
interval longer than in other sites inside the scar area.20,21 Several 
studies have been shown that LPs can be used as targets of catheter 
ablation for unmappable VT.22-25 According to the study of Vergara 
et al., complete abolition of LPs predicts arrhythmic recurrences. 
Indeed, they found arrhythmic recurrences only in 9.5% of patients 
in which LPs were eliminated at the end of the procedure. Complete 
abolition of LPs over the scar area represents an effective strategy of 
substrate modification for the ablation of scar-related VT.26
Recently, Efremidis and coworkers reported a case of effective 
radiofrequency ablation of VT in a patient with Naxos disease in 
which at the site of earliest endocardial activation was found a LPs 
area. The entire area of LPs were targeted and ablated resulting in 
non-inducibility of VT.27
Moreover, it has been demonstrated that, adjusting the voltage 
cutoffs that define the scar, it is possible to identify conducting 
channels in the setting of ischemic cardiomyopathy.28,29 As previously 
described by Arenal et al. and Bogun et al. these “corridors” of slow 
conduction within the scar often contain LPs.21,22 However, if large 
scars are present, the use of these channels alone in identifying the 
critical isthmus has low specificity, and therefore their ability to 
accurately guide ablation is poor. Mountantonakis and coworkers 
demonstrated that the presence of LPs within a channel increases 
the likelihood that the channel will be important for maintaining 
VT.30 In patients with ARVC/D, Berruezo et al. showed that a 
combined endo-epicardial approach including complete elimination 
of all conducting channels, so-called scar dechannelling technique, 
achieves a high acute success rate with low incidence of recurrence 
during a one year follow-up.31
Ablation Using MRI Technology
Preprocedural cardiac MRI is valuable due to its ability to provide 
high-resolution anatomic mapping and tissue characterization in 
the absence of ionizing radiation. DE-MRI can be used to localize 
the arrhythmia substrate within the chamber of interest prior to the 
procedure. There is growing evidence that DE-MRI may be useful in 
patients with AF in terms of treatment decisions and assessment of 
ablation efficacy.
Over the past twenty years, technologies for the treatment of 
both supraventricular and ventricular arrhythmias has significantly 
advanced and ablation is now the first-line therapy for many 
arrhythmias.32-34 As mentioned above current catheter-based 
techniques employ EAM provides real-time guidance for the 
operator during the procedure.35 Image fusion techniques that merge 
chamber morphology data from preprocedural MRI or CT with 
intraprocedural anatomical and electrical data are now widely used for 
accurate depiction of critical anatomic details that aid in the selection 
of ablation sites. Given its strengths in non-invasive identification of 
myocardial fibrosis, an anatomical substrate for arrhythmia, contrast-
enhanced cardiac MRI has an emerging role in anatomic mapping of 
scar and ablation planning.36
Magnetic Resonance Imaging and Atrial Fibrillation
Magnetic Resonance Imaging (MRI) basally was used for EAM 
mainly for fusion of volumetric MRI data obtained during the 
procedure. The MRI anatomic map precisely defines the anatomy 
of the chamber of interest, which is particularly important in AF 
ablation. MRI is useful in the pulmonary vein’s (PV) anatomy 
evaluation. The left atrium (LA) and PVs are accurately visualized.14 
infarct patients and normal controls, the presently used cut-off values 
of >1.5 mV for normal myocardium and <0.5 mV for dense scar were 
derived. Amplitudes between 0.5 mV and 1.5 mV were found to 
be present at the edges of dense infarct scars and corresponded to 
the scar border zone. EAM can be performed if a particular cardiac 
chamber can be reached and mapped with a mapping catheter.10 In 
addition to bipolar EGM amplitude, bipolar EGM duration and 
fractionation were also found in similar early studies to be increased 
in the presence of scarring because of electrical uncoupling of adjacent 
myocytes by islands or shards of replacement or interstitial fibrosis,11 
which is necessary conditions for the development of reentrant 
arrhythmias. Adequate catheter contact with the myocardial wall, 
however, is a requirement for an adequate voltage map (figure 1). 
Bipolar recording more accurately reflects local changes in electrical 
activity and is less influenced by far-field electrical activity, possibly 
explaining its ability to provide information about intramural scar 
location but still unable to predict transmural depth.  More recently, 
and particularly in the setting of non-ischemic cardiomyopathy 
where epicardial and intramural substrate predominates, the utility 
of unipolar EGM amplitude for the delineation of deeper layers 
of more diffuse fibrosis has been demonstrated, both in the right 
and left ventricles.12 Hutchinson et al. assessed the role of unipolar 
recording during voltage maps created during VT ablation.13 In 11 
patients with epicardial low voltage regions noted during epicardial 
mapping, 9/11 patients had corresponding low voltage (≤ 8.27 mV) 
unipolar recording from the endocardial surface. This data suggested 
that unipolar recording might have a greater field of view, which 
could predict an epicardial substrate during endocardial mapping. 
This same methodology was used to assess the RV epicardium in 
patients with ARVC/D with an endocardial unipolar voltage of <5.5 
mV indicative of an epicardial low voltage region.14 The presence 
of a critical extent of unipolar-defined substrate (>32% of total LV 
endocardial surface) has now been shown to predict non-reversibility 
of non-ischemic cardiomyopathy, consistent with detection of a 
critical diffuse burden of irreversible microfibrosis that may not be 
identified with bipolar recording or standard MRI techniques.
Late Potential Activity, Voltage Map Channels And Scar 
dechannelling Technique
Late potentials (LPs) are high frequency, low amplitude, microvolt-
size signals at the end of the QRS complex related to fragmented 
and delayed electrical activity in the ventricles. LPs were detected 
in patients with ventricular arrhythmias, ventricular aneurysms and 
ARVC/D. LPs are associated with reentry mechanism responsible 
for the induction of sustained VT and it has been reported a higher 
frequency of sudden cardiac death. LPs can be identified non-
invasively using a quick and inexpensive diagnostic tool, the signal 
averaged electrocardiogram (SAECG).15-17 However, conventional 
SAECG criteria for the presence of LPs in patients with a prolonged 
QRS duration are inaccurate. As reported by Gatzoulis et al. 
modification of these criteria is necessary to obtain useful information 
in these patients.18
Invasively, LPs activity is a discrete bipolar electrical signal recorded 
after the prevalent EGM occurring after the end of the surface QRS 
complex. LPs are marker of slow conduction and can be used to 
identify the critical isthmus of the reentry circuit of VT19 (Figure 2). 
Pacemapping from LPs sites allows an 11/12 or 12/12 concordance 
with VT morphology more frequently than in other low amplitude 
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difference between gadolinium retention in normal tissues versus 
fibrotic myocardium is maximal at approximately 10–20 min after 
contrast administration, which is the optimal time for obtaining 
DE images.46 These sequences are further optimized for maximal 
contrast between normal tissue and scar by applying a 180° inversion 
recovery pulse before image acquisition. The 180° pulse has the 
effect of flipping the magnetic moment of the spinning protons 180° 
from their equilibrium position. In the setting of acute myocardial 
infarction (MI), myocardial necrosis results in disruption of 
myocyte membranes, allowing increased space for the distribution 
of gadolinium. In the setting of chronic MI, collagenous scar tissue 
has replaced the necrotic tissue and the increase in interstitial MRI 
allows for exact anatomic reconstruction of cardiac anatomy, and can 
be used in conjunction with DE to localize scar tissue. In the setting 
of chronic MI, collagenous scar tissue has replaced the necrotic 
tissue and the increase in interstitial tissue increases the volume of 
distribution for gadolinium, resulting in hyperenhancement. Initial 
studies used a signal intensity of 2–3 standard deviations above 
normal appearing myocardium in order to define the presence of 
DE.47
MRI And Arrhythmogenic Right Ventricular 
Cardiomyopathy/Dysplasia 
Cardiac MRI plays a key role in the diagnosis of ARVC/D. High 
resolution cine imaging is widely considered the gold standard for the 
quantitative assessment of RV volume and systolic function. The high 
spatial and temporal resolution enables a detailed assessment of the 
RV for regional wall motion abnormalities. The modified Task Force 
Criteria include an assessment of a combination of RV function and 
wall motion abnormalities. RV volumes have been adjusted for body 
surface area and sex. Previous criteria that included wall thinning, 
and fatty infiltrations, as well as wall motion abnormalities such as 
hypokinesis, have been abandoned for akinetic and dyskinetic wall 
motions in order to achieve higher specificity.48 Fibro-fatty tissue 
has been described in ARVC/D, and DE-MRI has also been found 
to indicate scar tissue in this particular cardiomyopathy (Figure 
3). Inducibility of VT does correlate with the presence of DE. 
Correlations of abnormalities within the MRI and electrophysiologic 
findings such as low voltage areas have been done in a qualitative 
manner in small series of patients.49
MRI And Other Forms Of Non-Ischemic Cardiomyopathy
DE-MRI has been used to differentiate various forms of 
cardiomyopathy. Mid-wall DE has become the imaging hallmark 
of idiopathic dilated cardiomyopathy. Patchy multifocal DE with 
a basal and septal involvement preferentially affecting the mid- 
and epicardial myocardium is typically seen in cardiac sarcoidosis 
The presence of scar by DE-MRI has been correlated with the 
spontaneous occurrence of VT as well as the inducibility of VT and 
outcome in patients with non-ischemic cardiomyopathy.50,51 In the 
setting of non-ischemic cardiomyopathy, it is important perform 
adequate scar imaging with cardiac MRI to assess the etiology of the 
cardiomyopathy prior to implantation of a cardioverter defibrillator. 
Identification of scar tissue in patients with idiopathic dilated 
cardiomyopathy or cardiac sarcoidosis has been useful in assisting 
with mapping and ablation of ventricular arrhythmias. As described 
by Bogun it has valuable role to identify the location of the scar if 
corresponds to the location of the arrhythmogenic substrate.52 If 
the scar was located endocardially, all arrhythmias were mapped to 
MRI has also been used to define the location of the esophagus 
relative to the LA that may reduce the risk of esophageal injury.37
In the last years new techniques for evaluation of DE within the 
LA have recently been developed.38,39
Left atrial imaging is technically challenging, as the thin walls of 
the LA demand very high spatial and contrast resolution that push 
the boundaries of current MRI technology. Detecting fibrosis in the 
LA wall using MRI was first applied by Marrouche group at the 
CARMA Center, and enabled them to visualise the location, extent, 
and amount of atrial fibrotic changes. In this study the LA was 
scanned using late gadolinium enhancement to evaluate the extent of 
enhancement in the LA before AF ablation, and correlated with low 
voltage area in EAM (CARTO; Biosense Webster, Diamond Bar, 
California, USA) during AF ablation.40
Although several studies have been conducted to determine 
predictors of AF recurrences following catheter ablations, identifying 
the ideal candidate for catheter ablation of AF remains a significant 
challenge. Akoum et al. reported important data that can be utilised 
for personalising the strategy of AF ablation.41 Based on the amount 
of pre-ablation DE in the LA wall patients are divided into four 
stages of left atrial structural remodelling. Utah stage I is defined 
as ≤5% enhancement (minimal), Utah stage II as >5% and ≤20% 
enhancement (mild), Utah stage III as >20% and ≤35% enhancement 
(moderate), and Utah stage IV as >35% enhancement (extensive). 
Patients with minimal left atrial fibrosis (Utah stage I) had excellent 
results after AF ablation, whereas poor results were obtained in 
patients with extensive left atrial structural remodelling (Utah stage 
IV). 
DE-MRI has been used also to identify ablation lesions in the left 
atrial wall and surrounding the PVs, as well as gaps in circumferential 
PV isolation that are associated with increased risk of recurrence.38,42
For the first time the group of Marrouche also demonstrated that 
the large areas marked as ablated in the EAM did not result in long-
term scar and could well be the reason for high recurrence rates of 
arrhythmias like AF.43
Scar Mapping Using Delayed Enhancement MRI
DE-MRI is considered the gold standard for imaging of scar tissue. 
In patients with structural heart disease, ventricular arrhythmias 
originate from scar tissue. Furthermore, in the presence of ventricular 
arrhythmias, cardiac MRI helps to rule in or rule out the presence 
of structural heart disease. We will focus on the use of DE-MRI to 
identify scar tissue in various cardiomyopathies, and the potential value 
for mapping and ablation of ventricular arrhythmias. Furthermore, 
we will discuss the value of MRI for ruling out structural heart 
disease. Cardiac MRI typically utilizes a T1-weighted fast gradient 
echo images acquired during a held breath. Maximal resolution is 
typically on the order of 1–2 mm for each dimension in the x, y and z 
planes. One potential pit-fall encountered with the use of registered 
3D images is loss of accurate positional data if the patient moves 
during the study, requiring repeat acquisition of reference points. The 
utility of DE imaging using cardiac MRI for the identification of 
ventricular myocardial scar has been well established.44 In myocardial 
fibrosis, the extracellular matrix is expanded due to replacement of 
normal myocytes with collagen. Gadolinium contrast agent washes 
in and out of normal myocardium relatively rapidly; however, it is 
retained within the fibrotic myocardium both due to the increased 
extracellular fluid volume and decreased capillary density.45 The 
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positioning and identifying potential target areas for RFCA.
Substrate mapping of VT involves characterization of areas 
likely to support reentry based on anatomy and electrophysiological 
characteristics. Substrate mapping typically begins with identification 
of the region of ventricular scar, based on electrogram characteristics.33
Since voltage is used to define scar, consistent catheter contact is 
necessary. If catheter contact is not sufficient (i.e. ridges, geometric 
distortions), the EAM could suggest an erroneous scar. For this 
reason, substrate mapping relies heavily on the correct interpretation 
of electrograms. Whilst using traditional EAM only those regions 
in which there is a good contact are correctly mapped, ICE imaging 
has potential advantages: ICE can reliably identify scar both by wall 
thickness and motion a process that does not require wall contact. 
Moreover, ICE allows to visualize all segments of the left ventricle 
from multiple planes in real-time.
The first experience that demonstrated the feasibility of ICE 
guidance for identifying the VT anatomical substrate was published 
by Bunch and co-workers.69 According to the authors ICE imaging 
was more accurate in prediction of scar borders than transthoracic 
echocardiography, particularly in the basal segments of the heart.
Bala et al. showed the usefulness of ICE in a series of patients with 
non-ischemic cardiomyopathy and recurrent VT.70 In these patients 
ICE imaging identified abnormal increased echogenicity in the 
lateral wall of the left ventricle. This substrate was characterized by 
detailed endocardial and epicardial mapping, analysis of electrograms 
in low-voltage areas and correlation with MRI and CT angiography. 
They found predominantly normal LV endocardial voltage and 
abnormal epicardial substrate identified by ICE imaging (Figure 5). 
In all patients detailed epicardial mapping revealed that areas of low 
amplitude, wide, split and late electrograms were related with areas 
of increased echogenicity. In a subset of patients, MRI confirmed 
abnormal substrate in the lateral wall, correlating to the ICE-defined 
abnormality. These areas can be successfully targeted for RFCA to 
provide effective VT control.
In concordance with these observations in patients with non-
ischemic VT, the anatomical VT substrate in the study of Hussein et 
al. was found to have increased echogenicity.71
Noteworthy, this study was extended to a population with both 
ischemic and non-ischemic VT patients. ICE was confirmed to have 
the potential to assess anatomical substrate characterization for VT 
ablations. In addition, using a software - Image J, Java-based standard 
image processing software, National Institutes of Health, Bethesda, 
MD - that allows measurement of signal intensity units in every 
pixel, a quantitative assessment of signal intensity and heterogeneity 
was performed in order to better characterize the VT scar and border 
zone on ICE images.72-75 Scar zones, identified on endocardial voltage 
maps, were found to have increased tissue echogenicity compared 
to myocardial areas without scar in ischemic and non-ischemic 
patients. Border zones were found to have more heterogeneous signal 
intensities than normal myocardium.
Computed Tomography
It is well known that epicardial catheter ablation for ventricular 
arrhythmias is an important therapeutic option not only after 
endocardial ablation failure but also as first approach especially in 
patients with non-ischemic cardiomyopathy. However, epicardial 
mapping and ablation in epicardial space may have limitations, in 
particular EAM and RFCA may be limited by the presence of coronary 
the endocardium. In the case of an epicardial scar, the origin of the 
arrhythmias was originating from the epicardium, which significantly 
ease mapping and ablation planning and orient the operator to the 
priority of epicardial approach from the beginning. In the case of 
intramural scars, only arrhythmias in which the scar extended to the 
endocardium or epicardium could be mapped and ablated from the 
endocardium or epicardium, respectively.
Intracardiac Echocardiography
During the past 20 years, electrophysiological procedures have been 
performed almost exclusively under fluoroscopic guidance. However, 
due to the need to reduce fluoroscopic exposure and the increased 
complexity of procedures, accurate imaging of intracardiac anatomic 
structures and interventional catheter devices has been required.53,54
Intracardiac echocardiography (ICE) has proved to be helpful for 
several practical uses in the setting of electrophysiological procedures, 
including: (1) identification and evaluation of the endocardial 
structures before and after procedure; (2) safe guidance of transseptal 
puncture, particularly in the setting of complex or unusual anatomy; 
(3) real-time determination of catheter placement relative to cardiac 
structures; (4) evaluation of catheter contact with cardiac tissues; (5) 
visualization of evolving lesions during radiofrequency (RF) energy 
delivery; (6) monitoring of complications.55-59
To date two different types of ICE imaging systems are available: 
the mechanical ultrasound catheter radial imaging system, a single, 
rotating, crystal ultrasound transducer mounted on a non-steerable 
9Fr catheter (Ultra ICE, EP Technologies, Boston Scientific 
Corp, San Jose, CA) and the electronic phased-array catheter 
sector imaging system, a forward-facing 64-element phased-array 
transducer scanning in the longitudinal plane mounted on the distal 
end of an 8 or 10 Fr 4-way steerable tip catheter (AcuNav, Acuson 
Corporation, Siemens Medical Solutions, Malvern, PA). A newer 
64-element phased-array and bidirectional curve ultrasound catheter 
(St. Jude Medical, St. Paul, MN) is the ViewFlex Plus which runs on 
the ViewMate ultrasound system (EPMedSystems, Inc., Berlin, NJ).
Moreover, the feasibility of the integration of EAM and intracardiac 
echocardiography has been demonstrated. The introduction of the 
CARTOSOUND Image Integration Module (Biosense Webster, 
Diamond Bar, CA) has expanded ICE applications. Indeed, the 
CARTOSOUND incorporates the electroanatomical map to an 
ICE 3D volume reconstruction of the cardiac chambers using real-
time ICE imaging.60-63
Despite a wide use of ICE imaging during RFCA for AF,64,65 
ICE has not been routinely used during RFCA for VT.53 Several 
studies have described that the use of ICE in VT ablation present 
the following advantages: to accurately guide and locate catheter 
placement on specific anatomic targets and confirm catheter 
contact with the endocardium; to guide transseptal access; to 
facilitate mapping and ablation of left ventricular outflow tract VT 
(visualization of coronary artery ostia and aortic cusp); to guide the 
subxiphoid pericardial puncture and visualize the puncture-related 
complications; and to monitor tissue injury and complications during 
the procedure (i.e. cardiac perforation and tamponade, valvular injury 
and thromboembolic events66-68 ICE imaging created volumes have 
been shown to accurately assist in VT ablation.63 In addition, recent 
studies focused on the ability of ICE to identify the arrhythmogenic 
substrate during VT ablation: scars, aneurysms, akinesia or dyskinesia 
(Figure 4). Adequate visualization of the akinetic and/or dyskinetic 
regions using ICE is feasible, enabling guidance of catheter 
Featured ReviewJournal of Atrial FibrillationJ r l f tri l i rill ti96 Journal i
www.jafib.com Dec 2014-Jan 2015| Volume 7| Issue 4
scar reconstruction based on magnetic resonance imaging. J Am Coll Cardiol 
2008;52(10): 839–42
10. Marchlinski FE, Callans DJ, Gottlieb CD, Zado ES. Linear ablation lesions 
for control of unmappable ventricular tachycardia in patients with ischemic and 
nonischemic cardiomyopathy. Circulation 2000;101(11):1288–96
11. Gardner PI, Ursell PC, Fenoglio JJ, Wit AL, “Electrophysiologic and anatomic 
basis for fractionated electrograms recorded from healed myocardial infarcts. 
Circulation 1985;72(3):596–611
12. Polin GM, Haqqani H, Tzou WS, Hutchinson MD, Garcia FC, Callans DJ, Zado 
ES, Marchlinski FE. Endocardial unipolar voltage mapping to identify epicardial 
substrate in arrhythmogenic right ventricular cardiomyopathy/dysplasia.,” Heart 
Rhythm 2011;8(1)76–83
13. Hutchinson MD, Gerstenfeld EP, Desjardins B, Bala R, Michael P, Garcia 
FC, Dixit S, Lin D, Tzou WS, Cooper JM, Ralph J, Callans DJ, Marchlinski 
FE. Endocardial Unipolar Voltage Mapping to Detect Epicardial Ventricular 
Tachycardia Substrate in Patients With Nonischemic Left Ventricular 
Cardiomyopathy. Circ Arrhythm Electrophysiol 2011;4(1):49-55
14. Kato R, Lickfett L, Meininger G, Dickfeld T, Wu R, Juang G, Angkeow P, 
LaCorte J, Bluemke D, Berger R, Halperin HR, Calkins CH. Pulmonary vein 
anatomy in patients undergoing catheter ablation of atrial fibrillation: lessons 
learned by use of magnetic resonance imaging. Circulation 2003;107(15):2004–10
15. Simson MB. Clinical application of signal averaging. Cardiol Clin 1983;1:109-19
16. Denes P, Santarelli P, Hauser RG, Uretz EF. Quantitative analysis of the high-
frequency components of the terminal portion of the body surface QRS in normal 
subjects and in patients with ventricular tachycardia. Circulation 1983; 67: 1129-
38
17. Ohnishi Y, Inoue T, Fukuzaki H. Value of the signal-averaged electrocardiogram 
as a predictor of sudden death in myocardial in the dilated cardiomyopathy. Jpn 
Circ J 1990; 127-36
18. Gatzoulis KA, Carlson MD, Biblo LA, Rizos I, Gialafos J, Toutouzas P, Waldo 
AL. Time domain analysis of the signal averaged electrocardiogram in patients 
with a conduction defect or a bundle branch block. Eur Heart J 1995;16(12):1912-
9
19. de Bakker JM, Wittkampf FH. The pathophysiologic basis of fractionated and 
complex electrograms and the impact of recording techniques on their detection 
and interpretation. Circ Arrhythm Electrophysiol 2010;3:204-213
20. Hsia HH, Lin D, Sauer WH, Callans DJ, Marchlinski FE. Relationship of late 
potentials to the ventricular tachycardia circuit defined by entrainment. J Interv 
Card Electrophysiol 2009;26:21-29
21. Bogun F, Good E, Reich S, Elmouchi D, Igic P, Lemola K, Tschopp D, 
Jongnarangsin K, Oral H, Chugh A, Pelosi F, Morady F. Isolated potentials 
during sinus rhythm and pace-mapping within scars as guides for ablation of post-
infarction ventricular tachycardia. J Am Coll Cardiol 2006;47:2013-2019
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Jongnarangsin K, Pelosi F Jr, Oral H, Morady F, Bogun FM. Isolated potentials 
and pace-mapping as guides for ablation of ventricular tachycardia in various types 
of nonischemic cardiomyopathy. J Cardiovasc Electrophysiol 2010;21:1017-1023
25. Nakahara S, Tung R, Ramirez RJ, Michowitz Y, Vaseghi M, Buch E, Gima J, Wiener 
I, Mahajan A, Boyle NG, Shivkumar K. Characterization of the arrhythmogenic 
arteries and epicardial fat. CT is a reliable imaging technique that 
allows visualization of the coronary arteries and epicardial fat.76,77 The 
group of Zeppenfeld recently evaluated the feasibility and accuracy 
of accurate real-time integration of CT-derived coronary artery 
anatomy and fat distribution during the ablation procedure.78 After 
registration of a single coronary injection, the distance between target 
sites of ablation and coronary arteries can be accurately evaluated by 
integrated CT, with a mean surface error of only 2.8 mm. Moreover, 
in contrast to previous observations, the authors demonstrated that 
unipolar voltage is not influenced by epicardial fat, probably because 
the larger field of view.13,79 Therefore, unipolar voltage mapping 
may be useful for identification of subepicardial or intramural scar 
even when thick fat is present. In conclusion, in this study a thick 
epicardial fat layer (>7 mm) and the presence of coronary arteries are 
important reasons for epicardial ablation failure. 
Conclusion:
The new imaging technologies are promising tools to better 
characterize the arrhythmic substrate. The high density mapping 
with the assessment of late, fragmented potentials and channels 
help to localize the critical isthmus in the complex arrhythmias. In 
addition, the real-time image integration of preacquired MRI and 
CT information is feasible and accurate to assess epicardial fat and 
coronary artery, important issues during epicardial ablation. Finally, 
ICE integration with EAM and catheter tip-tissue contact analysis 
provides optimization of the lesions during complex procedures.
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